Abbott is a global healthcare company headquartered in Chicago, founded in 1888 and employing approximately 115,000 people. Its operations span more than 160 countries, and it has appeared on Fortune's list of Most Admired Companies every year since 1984. The firm develops and manufactures technologies across a range of medical fields, with a particular emphasis on diagnostics, cardiovascular devices, diabetes care, and nutrition.
The company's technical work intersects with artificial intelligence through domains such as continuous glucose monitoring and biowearables. Products like the FreeStyle Libre system and the Lingo biowearable generate continuous health data streams, where AI and machine learning techniques are applied for data analysis, pattern recognition, and personalized health insights. Abbott's diagnostic platforms also leverage computational methods for testing and analysis at scale.
Key product lines include the FreeStyle Libre continuous glucose monitoring system, the AVEIR DR leadless pacemaker for cardiac rhythm management, and Lingo, a consumer biowearable. The company's stated purpose is to develop life-changing technologies that address pressing health needs through science and innovation.
